Although clinical trials for novel therapeutics in ALS patients are showing promising results, it remains useful to test new therapies in dogs with DM as an animal model for ALS, given significant overlap in the pathophysiology, especially the shared importance of the SOD1 gene in both diseases. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.